Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

ClinicalTrials.gov ID: NCT03933202

Public ClinicalTrials.gov record NCT03933202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effectiveness, safety and Patient-Reported Outcomes (PROs) of cladribine tablets in participants with RMS including relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive multiple sclerosis (aSPMS), who transition to cladribine tablets after suboptimal response to any oral or infusion Disease-Modifying Drugs (DMDs) approved in the United States (US) for RMS in a real-world-setting.

Study identification

NCT ID
NCT03933202
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
291 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2019 (Actual)
Primary completion
Nov 11, 2024 (Actual)
Completion
Nov 11, 2024 (Actual)
Last update posted
Jan 2, 2026

2019 – 2024

United States locations

U.S. sites
66
U.S. states
26
U.S. cities
61
Facility City State ZIP Site status
North Central Neurology Associates, P.C. Cullman Alabama 35058 —
University of South Alabama Mobile Alabama 36693 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Fullerton Neurology and Headache Center Fullerton California 92835 —
Regina Berkovich MD PhD INC West Hollywood California 90048 —
Colorado Springs Neurological Associates, PC - Neurology Colorado Springs Colorado 80907 —
HCA Research Institute Englewood Colorado 80113 —
Advanced Neurosciences Research, LLC Fort Collins Colorado 80528 —
Associated Neurologists of Southern Connecticut, PC Fairfield Connecticut 06824 —
Yale University Fairfield Connecticut 06824 —
Neurology Associates, P. A. Maitland Florida 32751 —
University of Miami Miami Florida 33136 —
Orlando Health Multiple Sclerosis Comprehensive Care Center - Downtown Orlando Orlando Florida 32806 —
Suncoast Neuroscience and Associates, Inc. St. Petersburg Florida 33713 —
Axiom Clinical Research of Florida Tampa Florida 33609 —
University of South Florida Tampa Florida 33612 —
Northwest Neurology Ltd Rolling Meadows Illinois 60008 —
Prairie Education & Research Springfield Illinois 62702 —
Fort Wayne Neurological Center Fort Wayne Indiana 46804 —
College Park Family Care Center Overland Park Kansas 66212 —
Baptist Health Lexington Lexington Kentucky 40503 —
Northern Light Comprehensive Multiple Sclerosis Care Center Bangor Maine 04401 —
Neurological Clinical Research Institute Boston Massachusetts 02114 —
Neuro Institute of New England P.C. Foxborough Massachusetts 02035 —
The Elliot Lewis Center for Multiple Sclerosis Care Wellesley Massachusetts 02481 —
UMASS - Neurology Worcester Massachusetts 01655 —
Wayne State University (WSU) - Multiple Sclerosis Treatment and Clinical Research Center (MS Center) - Department of Neurology Detroit Michigan 48201 —
Detroit Clinical Research Center, PC Farmington Hills Michigan 48334 —
Memorial Healthcare Owosso Michigan 48867 —
Minneapolis Clinic of Neurology - Neurology Golden Valley Minnesota 55422 —
Neurology Center of Las Vegas Las Vegas Nevada 89128 —
DENT Neurologic Institute Amherst New York 14226 —
NYU Langone Brooklyn - Brooklyn Brooklyn New York 11220 —
The Trustee of Columbia University in the City of New York New York New York 10032 —
The Charlotte-Mecklenburg Hospital Authority - Carolinas Healthcare System Charlotte North Carolina 28203 —
Guilford Neurologic Associates Greensboro North Carolina 27405 —
Raleigh Neurology Associates Raleigh North Carolina 27607-6010 —
Insight Neuroscience LLC Bellevue Ohio 44811 —
Riverhills Neuroscience Cincinnati Ohio 45212 —
The Boster Center for Multiple Scelosis Columbus Ohio 43235 —
Dayton Center for Neurological Disorders Dayton Ohio 45459 —
University of Toledo - PARENT Toledo Ohio 43614-2598 —
Providence Neurological Specialties Portland Oregon 97225 —
Wills Eye Institute - Ocular Oncology Service - Wills Eye Institute Philadelphia Pennsylvania 19107 —
Premier Neurology Research, P.C. Greer South Carolina 29650 —
Neurology, PC Knoxville Tennessee 37922 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Northwest Houston Neurology Cypress Texas 77429 —
Baylor College of Medicine IRB Houston Texas 77030 —
DHR Health Neurology Institute Neuroimmunology and Multiple Sclerosis McAllen Texas 78503 —
Central Texas Neurology Consultants Round Rock Texas 78681 —
Neurology Center of San Antonio San Antonio Texas 78258 —
Integrated Neurology Services - Dr. Simon Fishman's Office Alexandria Virginia 22310 —
Blacksburg Neurology, PC Christiansburg Virginia 24073 —
Meridian Clinical Research (Neurology) Norfolk Virginia 23502 —
Neurological Associates Richmond Virginia 23226 —
VCU Medical Center - Pediatric Neurology Richmond Virginia 23298-0211 —
Massey Cancer Center - VCU Medical Center Richmond Virginia 23298 —
Multiple Sclerosis Center of Greater Washington Vienna Virginia 22182 —
Sentara Ambulatory Care Center Virginia Beach Virginia 23456 —
MS Center of Evergreen Kirkland Washington 98034 —
MultiCare Health System Institute for Research and Innovation - MultiCare Health System Institute for Research and Spokane Washington 99202 —
MultiCare Health System Institute for Research and Innovation - MultiCare Health System Institute for Research Tacoma Washington 98405 —
Ascension St. Francis Center for Neurological Disorders, S.C. Milwaukee Wisconsin 53215 —
The Medical College of Wisconsin - Endocrinology Milwaukee Wisconsin 53226 —
Neuroscience Group of Northeast Wisconsin - DUPLICATE Neenah Wisconsin 54956 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03933202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03933202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →